Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Kimia Biosciences has informed that it has been awarded a contract by a reputed client based in Europe. The total value of the contract is $200,000. The contract is related to Contract development and manufacturing organization (CDMO) and is expected to contribute significantly to the company’s revenue for the current financial year. This is for your information and records. Kindly take the same on record.
The above information is a part of company’s filings submitted to BSE.
